Useful resources |
Methotrexate for multiple sclerosis (Cochrane Review) ABSTRACT Background: Methotrexate is a potent immunosuppressant which in theory could reduce relapse rates and delay disease progression in multiple sclerosis (MS). Subsequently, clinical trials of methotrexate have been conducted in people with MS. |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |